
Keywords: urinary bladder; carcinoma; urachus; prognosis; biomarkers; BGN; biglycan; IHC; immunohistochemistry; IMP3; insulin-like growth factor II mRNA-binding protein 3; Ki67; nuclear protein Ki67; MMP-7; matrix metalloproteinase-7; OS; overall survival; p53; tum